Cancer Prevention II

Editors:

ISBN: 978-3-540-69296-6 (Print) 978-3-540-69297-3 (Online)

Table of contents (22 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xx

  2. Cancer Prevention and Health Politics

    1. No Access

      Book Chapter

      Pages 3-17

      Do We Make Optimal Use of the Potential of Cancer Prevention?

    2. No Access

      Book Chapter

      Pages 19-31

      Predictors of Successful Cancer Prevention Programs

    3. No Access

      Book Chapter

      Pages 33-39

      Cancer Prevenpinon in the Developing World: Mission Impossible?

    4. No Access

      Book Chapter

      Pages 41-47

      Is Cancer Prevention Ever Going to Be Profitable?

  3. Cancer Prevention: The Scientific-Epidemiological Base

    1. No Access

      Book Chapter

      Pages 51-54

      Energy Metabolism, Cancer Risk, and Cancer Prevention

    2. No Access

      Book Chapter

      Pages 55-59

      Promises and Limitations of Biomarkers

  4. Cancer Prevention, Tobacco and Nutrition

    1. No Access

      Book Chapter

      Pages 63-70

      The EPIC Study: An Update

    2. No Access

      Book Chapter

      Pages 71-76

      Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.

    3. No Access

      Book Chapter

      Pages 77-81

      Retinoids and Breast Cancer Prevention

  5. Cancer Prevention, Genetics and Vaccines

    1. No Access

      Book Chapter

      Pages 85-94

      Cancer Prevention by Vaccination Against Hepatitis B

  6. Cancer Prevention and Target Organs I: Breast Cancer

    1. No Access

      Book Chapter

      Pages 97-111

      Energy Restriction for Breast Cancer Prevention

    2. No Access

      Book Chapter

      Pages 113-119

      The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer

    3. No Access

      Book Chapter

      Pages 121-134

      Prevention of ER-Negative Breast Cancer

    4. No Access

      Book Chapter

      Pages 135-157

      EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?

  7. Cancer Prevention and Target Organs II: Cancer of the Digestive Tract

    1. No Access

      Book Chapter

      Pages 161-169

      Chemoprevention of Oesophageal Cancer and the AspECT Trial

  8. Cancer Prevention and Target Organs III: Prostate Cancer

    1. No Access

      Book Chapter

      Pages 173-182

      Review of Diagnostic Markers for Prostate Cancer 16

    2. No Access

      Book Chapter

      Pages 183-193

      Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention

    3. No Access

      Book Chapter

      Pages 195-205

      Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies

  9. Cancer Prevention and Target Organs III: Prostate Cancer

    1. No Access

      Book Chapter

      Pages 209-212

      Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids

  10. Aspirin and NSAIDs in Cancer Prevention: Attempts at an International Consensus

    1. No Access

      Book Chapter

      Pages 215-221

      Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer

previous Page of 2